cilazaprilat has been researched along with Injury, Myocardial Reperfusion in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, BF; Gerlach, E; Habazettl, H; Kupatt, C; Messmer, K; Weber, C; Zahler, S | 1 |
| Hori, M; Kitakaze, M; Kosaka, H; Minamino, T; Mori, H; Node, K | 1 |
| Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
| Becker, BF; Kupatt, C; Zahler, S | 1 |
4 other study(ies) available for cilazaprilat and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Adhesion; Cilazapril; Coronary Vessels; Flow Cytometry; Guinea Pigs; Macrophage-1 Antigen; Male; Microscopy, Fluorescence; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Perfusion | 1997 |
Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium; Cilazapril; Collateral Circulation; Coronary Circulation; Data Interpretation, Statistical; Dogs; Enzyme Inhibitors; Epoprostenol; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptides; Potassium Channels; Scorpion Venoms; Time Factors; Toxins, Biological | 1998 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
ACE-inhibition attenuates cardiac cell damage and preserves release of NO in the postischemic heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide | 1999 |